Pharma & Healthcare
Global Mercaptopurine Tablets Market Research Report 2025
- Apr 16, 25
- ID: 201387
- Pages: 78
- Figures: 84
- Views: 1
The global market for Mercaptopurine Tablets was valued at US$ 43.1 million in the year 2024 and is projected to reach a revised size of US$ 59 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Mercaptopurine is used alone or with other chemotherapy drugs to treat acute lymphocytic leukemia. Mercaptopurine is in a class of medications called purine antagonists.
North American market for Mercaptopurine Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mercaptopurine Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mercaptopurine Tablets include Stason Pharmaceuticals, Dr. Reddy's Laboratories, Hikma Pharmaceuticals, Viatris, Sinopharm, Zhejiang Hisun Pharmaceutical, Guangzhou Baiyunshan Guanghua Pharmaceutical, China Resources Double-Crane Pharmaceutical, Zhejiang Zhebei Pharmaceutical, Shaanxi Hantang Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mercaptopurine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mercaptopurine Tablets.
The Mercaptopurine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mercaptopurine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mercaptopurine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Stason Pharmaceuticals
Dr. Reddy's Laboratories
Hikma Pharmaceuticals
Viatris
Sinopharm
Zhejiang Hisun Pharmaceutical
Guangzhou Baiyunshan Guanghua Pharmaceutical
China Resources Double-Crane Pharmaceutical
Zhejiang Zhebei Pharmaceutical
Shaanxi Hantang Pharmaceutical
Segment by Type
25mg
50mg
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mercaptopurine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mercaptopurine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Mercaptopurine is used alone or with other chemotherapy drugs to treat acute lymphocytic leukemia. Mercaptopurine is in a class of medications called purine antagonists.
North American market for Mercaptopurine Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mercaptopurine Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mercaptopurine Tablets include Stason Pharmaceuticals, Dr. Reddy's Laboratories, Hikma Pharmaceuticals, Viatris, Sinopharm, Zhejiang Hisun Pharmaceutical, Guangzhou Baiyunshan Guanghua Pharmaceutical, China Resources Double-Crane Pharmaceutical, Zhejiang Zhebei Pharmaceutical, Shaanxi Hantang Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mercaptopurine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mercaptopurine Tablets.
The Mercaptopurine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mercaptopurine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mercaptopurine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Stason Pharmaceuticals
Dr. Reddy's Laboratories
Hikma Pharmaceuticals
Viatris
Sinopharm
Zhejiang Hisun Pharmaceutical
Guangzhou Baiyunshan Guanghua Pharmaceutical
China Resources Double-Crane Pharmaceutical
Zhejiang Zhebei Pharmaceutical
Shaanxi Hantang Pharmaceutical
Segment by Type
25mg
50mg
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mercaptopurine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mercaptopurine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Mercaptopurine Tablets Market Overview
1.1 Product Definition
1.2 Mercaptopurine Tablets by Type
1.2.1 Global Mercaptopurine Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 25mg
1.2.3 50mg
1.3 Mercaptopurine Tablets by Application
1.3.1 Global Mercaptopurine Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mercaptopurine Tablets Market Size Estimates and Forecasts
1.4.1 Global Mercaptopurine Tablets Revenue 2020-2031
1.4.2 Global Mercaptopurine Tablets Sales 2020-2031
1.4.3 Global Mercaptopurine Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mercaptopurine Tablets Market Competition by Manufacturers
2.1 Global Mercaptopurine Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mercaptopurine Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mercaptopurine Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mercaptopurine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mercaptopurine Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mercaptopurine Tablets, Product Type & Application
2.7 Global Key Manufacturers of Mercaptopurine Tablets, Date of Enter into This Industry
2.8 Global Mercaptopurine Tablets Market Competitive Situation and Trends
2.8.1 Global Mercaptopurine Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mercaptopurine Tablets Players Market Share by Revenue
2.8.3 Global Mercaptopurine Tablets Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mercaptopurine Tablets Market Scenario by Region
3.1 Global Mercaptopurine Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mercaptopurine Tablets Sales by Region: 2020-2031
3.2.1 Global Mercaptopurine Tablets Sales by Region: 2020-2025
3.2.2 Global Mercaptopurine Tablets Sales by Region: 2026-2031
3.3 Global Mercaptopurine Tablets Revenue by Region: 2020-2031
3.3.1 Global Mercaptopurine Tablets Revenue by Region: 2020-2025
3.3.2 Global Mercaptopurine Tablets Revenue by Region: 2026-2031
3.4 North America Mercaptopurine Tablets Market Facts & Figures by Country
3.4.1 North America Mercaptopurine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mercaptopurine Tablets Sales by Country (2020-2031)
3.4.3 North America Mercaptopurine Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mercaptopurine Tablets Market Facts & Figures by Country
3.5.1 Europe Mercaptopurine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mercaptopurine Tablets Sales by Country (2020-2031)
3.5.3 Europe Mercaptopurine Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mercaptopurine Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Mercaptopurine Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mercaptopurine Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Mercaptopurine Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mercaptopurine Tablets Market Facts & Figures by Country
3.7.1 Latin America Mercaptopurine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mercaptopurine Tablets Sales by Country (2020-2031)
3.7.3 Latin America Mercaptopurine Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mercaptopurine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Mercaptopurine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mercaptopurine Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mercaptopurine Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mercaptopurine Tablets Sales by Type (2020-2031)
4.1.1 Global Mercaptopurine Tablets Sales by Type (2020-2025)
4.1.2 Global Mercaptopurine Tablets Sales by Type (2026-2031)
4.1.3 Global Mercaptopurine Tablets Sales Market Share by Type (2020-2031)
4.2 Global Mercaptopurine Tablets Revenue by Type (2020-2031)
4.2.1 Global Mercaptopurine Tablets Revenue by Type (2020-2025)
4.2.2 Global Mercaptopurine Tablets Revenue by Type (2026-2031)
4.2.3 Global Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Mercaptopurine Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mercaptopurine Tablets Sales by Application (2020-2031)
5.1.1 Global Mercaptopurine Tablets Sales by Application (2020-2025)
5.1.2 Global Mercaptopurine Tablets Sales by Application (2026-2031)
5.1.3 Global Mercaptopurine Tablets Sales Market Share by Application (2020-2031)
5.2 Global Mercaptopurine Tablets Revenue by Application (2020-2031)
5.2.1 Global Mercaptopurine Tablets Revenue by Application (2020-2025)
5.2.2 Global Mercaptopurine Tablets Revenue by Application (2026-2031)
5.2.3 Global Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Mercaptopurine Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Stason Pharmaceuticals
6.1.1 Stason Pharmaceuticals Company Information
6.1.2 Stason Pharmaceuticals Description and Business Overview
6.1.3 Stason Pharmaceuticals Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Stason Pharmaceuticals Mercaptopurine Tablets Product Portfolio
6.1.5 Stason Pharmaceuticals Recent Developments/Updates
6.2 Dr. Reddy's Laboratories
6.2.1 Dr. Reddy's Laboratories Company Information
6.2.2 Dr. Reddy's Laboratories Description and Business Overview
6.2.3 Dr. Reddy's Laboratories Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Dr. Reddy's Laboratories Mercaptopurine Tablets Product Portfolio
6.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Company Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hikma Pharmaceuticals Mercaptopurine Tablets Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Mercaptopurine Tablets Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Sinopharm
6.5.1 Sinopharm Company Information
6.5.2 Sinopharm Description and Business Overview
6.5.3 Sinopharm Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sinopharm Mercaptopurine Tablets Product Portfolio
6.5.5 Sinopharm Recent Developments/Updates
6.6 Zhejiang Hisun Pharmaceutical
6.6.1 Zhejiang Hisun Pharmaceutical Company Information
6.6.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.6.3 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.6.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.7 Guangzhou Baiyunshan Guanghua Pharmaceutical
6.7.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
6.7.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
6.7.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.7.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments/Updates
6.8 China Resources Double-Crane Pharmaceutical
6.8.1 China Resources Double-Crane Pharmaceutical Company Information
6.8.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
6.8.3 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.8.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
6.9 Zhejiang Zhebei Pharmaceutical
6.9.1 Zhejiang Zhebei Pharmaceutical Company Information
6.9.2 Zhejiang Zhebei Pharmaceutical Description and Business Overview
6.9.3 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.9.5 Zhejiang Zhebei Pharmaceutical Recent Developments/Updates
6.10 Shaanxi Hantang Pharmaceutical
6.10.1 Shaanxi Hantang Pharmaceutical Company Information
6.10.2 Shaanxi Hantang Pharmaceutical Description and Business Overview
6.10.3 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.10.5 Shaanxi Hantang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mercaptopurine Tablets Industry Chain Analysis
7.2 Mercaptopurine Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mercaptopurine Tablets Production Mode & Process Analysis
7.4 Mercaptopurine Tablets Sales and Marketing
7.4.1 Mercaptopurine Tablets Sales Channels
7.4.2 Mercaptopurine Tablets Distributors
7.5 Mercaptopurine Tablets Customer Analysis
8 Mercaptopurine Tablets Market Dynamics
8.1 Mercaptopurine Tablets Industry Trends
8.2 Mercaptopurine Tablets Market Drivers
8.3 Mercaptopurine Tablets Market Challenges
8.4 Mercaptopurine Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Mercaptopurine Tablets by Type
1.2.1 Global Mercaptopurine Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 25mg
1.2.3 50mg
1.3 Mercaptopurine Tablets by Application
1.3.1 Global Mercaptopurine Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mercaptopurine Tablets Market Size Estimates and Forecasts
1.4.1 Global Mercaptopurine Tablets Revenue 2020-2031
1.4.2 Global Mercaptopurine Tablets Sales 2020-2031
1.4.3 Global Mercaptopurine Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mercaptopurine Tablets Market Competition by Manufacturers
2.1 Global Mercaptopurine Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mercaptopurine Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mercaptopurine Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mercaptopurine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mercaptopurine Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mercaptopurine Tablets, Product Type & Application
2.7 Global Key Manufacturers of Mercaptopurine Tablets, Date of Enter into This Industry
2.8 Global Mercaptopurine Tablets Market Competitive Situation and Trends
2.8.1 Global Mercaptopurine Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mercaptopurine Tablets Players Market Share by Revenue
2.8.3 Global Mercaptopurine Tablets Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mercaptopurine Tablets Market Scenario by Region
3.1 Global Mercaptopurine Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mercaptopurine Tablets Sales by Region: 2020-2031
3.2.1 Global Mercaptopurine Tablets Sales by Region: 2020-2025
3.2.2 Global Mercaptopurine Tablets Sales by Region: 2026-2031
3.3 Global Mercaptopurine Tablets Revenue by Region: 2020-2031
3.3.1 Global Mercaptopurine Tablets Revenue by Region: 2020-2025
3.3.2 Global Mercaptopurine Tablets Revenue by Region: 2026-2031
3.4 North America Mercaptopurine Tablets Market Facts & Figures by Country
3.4.1 North America Mercaptopurine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mercaptopurine Tablets Sales by Country (2020-2031)
3.4.3 North America Mercaptopurine Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mercaptopurine Tablets Market Facts & Figures by Country
3.5.1 Europe Mercaptopurine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mercaptopurine Tablets Sales by Country (2020-2031)
3.5.3 Europe Mercaptopurine Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mercaptopurine Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Mercaptopurine Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mercaptopurine Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Mercaptopurine Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mercaptopurine Tablets Market Facts & Figures by Country
3.7.1 Latin America Mercaptopurine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mercaptopurine Tablets Sales by Country (2020-2031)
3.7.3 Latin America Mercaptopurine Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mercaptopurine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Mercaptopurine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mercaptopurine Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mercaptopurine Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mercaptopurine Tablets Sales by Type (2020-2031)
4.1.1 Global Mercaptopurine Tablets Sales by Type (2020-2025)
4.1.2 Global Mercaptopurine Tablets Sales by Type (2026-2031)
4.1.3 Global Mercaptopurine Tablets Sales Market Share by Type (2020-2031)
4.2 Global Mercaptopurine Tablets Revenue by Type (2020-2031)
4.2.1 Global Mercaptopurine Tablets Revenue by Type (2020-2025)
4.2.2 Global Mercaptopurine Tablets Revenue by Type (2026-2031)
4.2.3 Global Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Mercaptopurine Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mercaptopurine Tablets Sales by Application (2020-2031)
5.1.1 Global Mercaptopurine Tablets Sales by Application (2020-2025)
5.1.2 Global Mercaptopurine Tablets Sales by Application (2026-2031)
5.1.3 Global Mercaptopurine Tablets Sales Market Share by Application (2020-2031)
5.2 Global Mercaptopurine Tablets Revenue by Application (2020-2031)
5.2.1 Global Mercaptopurine Tablets Revenue by Application (2020-2025)
5.2.2 Global Mercaptopurine Tablets Revenue by Application (2026-2031)
5.2.3 Global Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Mercaptopurine Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Stason Pharmaceuticals
6.1.1 Stason Pharmaceuticals Company Information
6.1.2 Stason Pharmaceuticals Description and Business Overview
6.1.3 Stason Pharmaceuticals Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Stason Pharmaceuticals Mercaptopurine Tablets Product Portfolio
6.1.5 Stason Pharmaceuticals Recent Developments/Updates
6.2 Dr. Reddy's Laboratories
6.2.1 Dr. Reddy's Laboratories Company Information
6.2.2 Dr. Reddy's Laboratories Description and Business Overview
6.2.3 Dr. Reddy's Laboratories Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Dr. Reddy's Laboratories Mercaptopurine Tablets Product Portfolio
6.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Company Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hikma Pharmaceuticals Mercaptopurine Tablets Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Mercaptopurine Tablets Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Sinopharm
6.5.1 Sinopharm Company Information
6.5.2 Sinopharm Description and Business Overview
6.5.3 Sinopharm Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sinopharm Mercaptopurine Tablets Product Portfolio
6.5.5 Sinopharm Recent Developments/Updates
6.6 Zhejiang Hisun Pharmaceutical
6.6.1 Zhejiang Hisun Pharmaceutical Company Information
6.6.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.6.3 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.6.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.7 Guangzhou Baiyunshan Guanghua Pharmaceutical
6.7.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
6.7.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
6.7.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.7.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments/Updates
6.8 China Resources Double-Crane Pharmaceutical
6.8.1 China Resources Double-Crane Pharmaceutical Company Information
6.8.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
6.8.3 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.8.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
6.9 Zhejiang Zhebei Pharmaceutical
6.9.1 Zhejiang Zhebei Pharmaceutical Company Information
6.9.2 Zhejiang Zhebei Pharmaceutical Description and Business Overview
6.9.3 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.9.5 Zhejiang Zhebei Pharmaceutical Recent Developments/Updates
6.10 Shaanxi Hantang Pharmaceutical
6.10.1 Shaanxi Hantang Pharmaceutical Company Information
6.10.2 Shaanxi Hantang Pharmaceutical Description and Business Overview
6.10.3 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product Portfolio
6.10.5 Shaanxi Hantang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mercaptopurine Tablets Industry Chain Analysis
7.2 Mercaptopurine Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mercaptopurine Tablets Production Mode & Process Analysis
7.4 Mercaptopurine Tablets Sales and Marketing
7.4.1 Mercaptopurine Tablets Sales Channels
7.4.2 Mercaptopurine Tablets Distributors
7.5 Mercaptopurine Tablets Customer Analysis
8 Mercaptopurine Tablets Market Dynamics
8.1 Mercaptopurine Tablets Industry Trends
8.2 Mercaptopurine Tablets Market Drivers
8.3 Mercaptopurine Tablets Market Challenges
8.4 Mercaptopurine Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Mercaptopurine Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Mercaptopurine Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Mercaptopurine Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Mercaptopurine Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Mercaptopurine Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Mercaptopurine Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Mercaptopurine Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Mercaptopurine Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Mercaptopurine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mercaptopurine Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mercaptopurine Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Mercaptopurine Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mercaptopurine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mercaptopurine Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mercaptopurine Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Mercaptopurine Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Mercaptopurine Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Mercaptopurine Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Mercaptopurine Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Mercaptopurine Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Mercaptopurine Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Mercaptopurine Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Mercaptopurine Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Mercaptopurine Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Mercaptopurine Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Mercaptopurine Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Mercaptopurine Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Mercaptopurine Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Mercaptopurine Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Mercaptopurine Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Mercaptopurine Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Mercaptopurine Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Mercaptopurine Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Mercaptopurine Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Mercaptopurine Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Mercaptopurine Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Mercaptopurine Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Mercaptopurine Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Mercaptopurine Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mercaptopurine Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Mercaptopurine Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Mercaptopurine Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Mercaptopurine Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Mercaptopurine Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Mercaptopurine Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Mercaptopurine Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Mercaptopurine Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Mercaptopurine Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Mercaptopurine Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Mercaptopurine Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Mercaptopurine Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Mercaptopurine Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Mercaptopurine Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Mercaptopurine Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Mercaptopurine Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Mercaptopurine Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Mercaptopurine Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Mercaptopurine Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Mercaptopurine Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Mercaptopurine Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Mercaptopurine Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Mercaptopurine Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Mercaptopurine Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Mercaptopurine Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. Stason Pharmaceuticals Company Information
Table 71. Stason Pharmaceuticals Description and Business Overview
Table 72. Stason Pharmaceuticals Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Stason Pharmaceuticals Mercaptopurine Tablets Product
Table 74. Stason Pharmaceuticals Recent Developments/Updates
Table 75. Dr. Reddy's Laboratories Company Information
Table 76. Dr. Reddy's Laboratories Description and Business Overview
Table 77. Dr. Reddy's Laboratories Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Dr. Reddy's Laboratories Mercaptopurine Tablets Product
Table 79. Dr. Reddy's Laboratories Recent Developments/Updates
Table 80. Hikma Pharmaceuticals Company Information
Table 81. Hikma Pharmaceuticals Description and Business Overview
Table 82. Hikma Pharmaceuticals Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Hikma Pharmaceuticals Mercaptopurine Tablets Product
Table 84. Hikma Pharmaceuticals Recent Developments/Updates
Table 85. Viatris Company Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Viatris Mercaptopurine Tablets Product
Table 89. Viatris Recent Developments/Updates
Table 90. Sinopharm Company Information
Table 91. Sinopharm Description and Business Overview
Table 92. Sinopharm Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sinopharm Mercaptopurine Tablets Product
Table 94. Sinopharm Recent Developments/Updates
Table 95. Zhejiang Hisun Pharmaceutical Company Information
Table 96. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 97. Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product
Table 99. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 100. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
Table 101. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
Table 102. Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product
Table 104. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments/Updates
Table 105. China Resources Double-Crane Pharmaceutical Company Information
Table 106. China Resources Double-Crane Pharmaceutical Description and Business Overview
Table 107. China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product
Table 109. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Zhebei Pharmaceutical Company Information
Table 111. Zhejiang Zhebei Pharmaceutical Description and Business Overview
Table 112. Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product
Table 114. Zhejiang Zhebei Pharmaceutical Recent Developments/Updates
Table 115. Shaanxi Hantang Pharmaceutical Company Information
Table 116. Shaanxi Hantang Pharmaceutical Description and Business Overview
Table 117. Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product
Table 119. Shaanxi Hantang Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Mercaptopurine Tablets Distributors List
Table 123. Mercaptopurine Tablets Customers List
Table 124. Mercaptopurine Tablets Market Trends
Table 125. Mercaptopurine Tablets Market Drivers
Table 126. Mercaptopurine Tablets Market Challenges
Table 127. Mercaptopurine Tablets Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mercaptopurine Tablets
Figure 2. Global Mercaptopurine Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mercaptopurine Tablets Market Share by Type: 2024 & 2031
Figure 4. 25mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. Global Mercaptopurine Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Mercaptopurine Tablets Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Mercaptopurine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Mercaptopurine Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Mercaptopurine Tablets Sales (2020-2031) & (K Units)
Figure 14. Global Mercaptopurine Tablets Average Price (US$/Unit) & (2020-2031)
Figure 15. Mercaptopurine Tablets Report Years Considered
Figure 16. Mercaptopurine Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Mercaptopurine Tablets Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Mercaptopurine Tablets Players: Market Share by Revenue in Mercaptopurine Tablets in 2024
Figure 19. Mercaptopurine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Mercaptopurine Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Mercaptopurine Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Mercaptopurine Tablets Revenue Market Share by Country (2020-2031)
Figure 23. United States Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Mercaptopurine Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Mercaptopurine Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Mercaptopurine Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Mercaptopurine Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Mercaptopurine Tablets Sales Market Share by Country (2020-2031)
Figure 42. Latin America Mercaptopurine Tablets Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Mercaptopurine Tablets Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Mercaptopurine Tablets Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Mercaptopurine Tablets by Type (2020-2031)
Figure 53. Global Revenue Market Share of Mercaptopurine Tablets by Type (2020-2031)
Figure 54. Global Mercaptopurine Tablets Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Mercaptopurine Tablets by Application (2020-2031)
Figure 56. Global Revenue Market Share of Mercaptopurine Tablets by Application (2020-2031)
Figure 57. Global Mercaptopurine Tablets Price (US$/Unit) by Application (2020-2031)
Figure 58. Mercaptopurine Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Mercaptopurine Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Mercaptopurine Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Mercaptopurine Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Mercaptopurine Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Mercaptopurine Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Mercaptopurine Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Mercaptopurine Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Mercaptopurine Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Mercaptopurine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mercaptopurine Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mercaptopurine Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Mercaptopurine Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mercaptopurine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mercaptopurine Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mercaptopurine Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Mercaptopurine Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Mercaptopurine Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Mercaptopurine Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Mercaptopurine Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Mercaptopurine Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Mercaptopurine Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Mercaptopurine Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Mercaptopurine Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Mercaptopurine Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Mercaptopurine Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Mercaptopurine Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Mercaptopurine Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Mercaptopurine Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Mercaptopurine Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Mercaptopurine Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Mercaptopurine Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Mercaptopurine Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Mercaptopurine Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Mercaptopurine Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Mercaptopurine Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Mercaptopurine Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Mercaptopurine Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Mercaptopurine Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Mercaptopurine Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mercaptopurine Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Mercaptopurine Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Mercaptopurine Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Mercaptopurine Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Mercaptopurine Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Mercaptopurine Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Mercaptopurine Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Mercaptopurine Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Mercaptopurine Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Mercaptopurine Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Mercaptopurine Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Mercaptopurine Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Mercaptopurine Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Mercaptopurine Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Mercaptopurine Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Mercaptopurine Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Mercaptopurine Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Mercaptopurine Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Mercaptopurine Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Mercaptopurine Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Mercaptopurine Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Mercaptopurine Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Mercaptopurine Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Mercaptopurine Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Mercaptopurine Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. Stason Pharmaceuticals Company Information
Table 71. Stason Pharmaceuticals Description and Business Overview
Table 72. Stason Pharmaceuticals Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Stason Pharmaceuticals Mercaptopurine Tablets Product
Table 74. Stason Pharmaceuticals Recent Developments/Updates
Table 75. Dr. Reddy's Laboratories Company Information
Table 76. Dr. Reddy's Laboratories Description and Business Overview
Table 77. Dr. Reddy's Laboratories Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Dr. Reddy's Laboratories Mercaptopurine Tablets Product
Table 79. Dr. Reddy's Laboratories Recent Developments/Updates
Table 80. Hikma Pharmaceuticals Company Information
Table 81. Hikma Pharmaceuticals Description and Business Overview
Table 82. Hikma Pharmaceuticals Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Hikma Pharmaceuticals Mercaptopurine Tablets Product
Table 84. Hikma Pharmaceuticals Recent Developments/Updates
Table 85. Viatris Company Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Viatris Mercaptopurine Tablets Product
Table 89. Viatris Recent Developments/Updates
Table 90. Sinopharm Company Information
Table 91. Sinopharm Description and Business Overview
Table 92. Sinopharm Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sinopharm Mercaptopurine Tablets Product
Table 94. Sinopharm Recent Developments/Updates
Table 95. Zhejiang Hisun Pharmaceutical Company Information
Table 96. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 97. Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product
Table 99. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 100. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
Table 101. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
Table 102. Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product
Table 104. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments/Updates
Table 105. China Resources Double-Crane Pharmaceutical Company Information
Table 106. China Resources Double-Crane Pharmaceutical Description and Business Overview
Table 107. China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product
Table 109. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Zhebei Pharmaceutical Company Information
Table 111. Zhejiang Zhebei Pharmaceutical Description and Business Overview
Table 112. Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product
Table 114. Zhejiang Zhebei Pharmaceutical Recent Developments/Updates
Table 115. Shaanxi Hantang Pharmaceutical Company Information
Table 116. Shaanxi Hantang Pharmaceutical Description and Business Overview
Table 117. Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product
Table 119. Shaanxi Hantang Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Mercaptopurine Tablets Distributors List
Table 123. Mercaptopurine Tablets Customers List
Table 124. Mercaptopurine Tablets Market Trends
Table 125. Mercaptopurine Tablets Market Drivers
Table 126. Mercaptopurine Tablets Market Challenges
Table 127. Mercaptopurine Tablets Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mercaptopurine Tablets
Figure 2. Global Mercaptopurine Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mercaptopurine Tablets Market Share by Type: 2024 & 2031
Figure 4. 25mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. Global Mercaptopurine Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Mercaptopurine Tablets Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Mercaptopurine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Mercaptopurine Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Mercaptopurine Tablets Sales (2020-2031) & (K Units)
Figure 14. Global Mercaptopurine Tablets Average Price (US$/Unit) & (2020-2031)
Figure 15. Mercaptopurine Tablets Report Years Considered
Figure 16. Mercaptopurine Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Mercaptopurine Tablets Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Mercaptopurine Tablets Players: Market Share by Revenue in Mercaptopurine Tablets in 2024
Figure 19. Mercaptopurine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Mercaptopurine Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Mercaptopurine Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Mercaptopurine Tablets Revenue Market Share by Country (2020-2031)
Figure 23. United States Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Mercaptopurine Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Mercaptopurine Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Mercaptopurine Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Mercaptopurine Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Mercaptopurine Tablets Sales Market Share by Country (2020-2031)
Figure 42. Latin America Mercaptopurine Tablets Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Mercaptopurine Tablets Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Mercaptopurine Tablets Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Mercaptopurine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Mercaptopurine Tablets by Type (2020-2031)
Figure 53. Global Revenue Market Share of Mercaptopurine Tablets by Type (2020-2031)
Figure 54. Global Mercaptopurine Tablets Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Mercaptopurine Tablets by Application (2020-2031)
Figure 56. Global Revenue Market Share of Mercaptopurine Tablets by Application (2020-2031)
Figure 57. Global Mercaptopurine Tablets Price (US$/Unit) by Application (2020-2031)
Figure 58. Mercaptopurine Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232